Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus Yanai Ben-Gal, MD, Yaron Moshkovitz, MD, Nachum Nesher, MD, Gideon Uretzky, MD, Rony Braunstein, PhD, Alberto Hendler, MD, Einat Zivi, BmedSc, Itzhak Herz, MD, Rephael Mohr, MD The Annals of Thoracic Surgery Volume 82, Issue 5, Pages 1692-1697 (November 2006) DOI: 10.1016/j.athoracsur.2006.05.080 Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Angina-free survival of Cypher versus coronary artery bypass grafting (CABG) groups (p = 0.0001, log-rank test). The Annals of Thoracic Surgery 2006 82, 1692-1697DOI: (10.1016/j.athoracsur.2006.05.080) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Reintervention-free survival of Cypher versus coronary artery bypass grafting (CABG) groups (p = 0.04, log-rank test). The Annals of Thoracic Surgery 2006 82, 1692-1697DOI: (10.1016/j.athoracsur.2006.05.080) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions